Form 4: Verona Pharma Director Christina Ackermann Awarded Restricted Share Units

Director Christina Ackermann receives an award of 96,000 Restricted Share Units (RSUs) convertible to American Depositary Shares (ADSs) of Verona Pharma plc.

Summary

• Christina Ackermann, a director of Verona Pharma plc, was granted 96,000 Restricted Share Units (RSUs) on April 25, 2025.
• Each RSU represents the right to receive one American Depositary Share (ADS), and each ADS represents eight ordinary shares of Verona Pharma.
• The RSUs will vest in four equal installments of 25% each on August 1, 2025, November 1, 2025, February 1, 2026, and May 1, 2026, contingent upon continued service to the Issuer.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of RSUs is a standard practice and indicates confidence in the director's continued contribution to the company. It's a positive sign for alignment of interests.

Positives

• The award of RSUs aligns the director's interests with those of the shareholders, incentivizing continued service and contribution to the company's success.

Risks

• The vesting of the RSUs is contingent upon the director's continued service, creating a potential risk if the director were to leave the company before all RSUs are vested.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the RSUs.

Industry Context

Equity compensation is a common practice in the pharmaceutical industry to attract and retain key personnel, aligning their interests with the long-term success of the company.

Comparison to Industry Standards

• RSU grants are a standard form of executive compensation in the pharmaceutical industry, often used by companies like Verona Pharma to incentivize performance and retain key talent.
• The vesting schedule of the RSUs is fairly typical, with quarterly vesting over a one-year period, which is a common practice among publicly traded companies.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it aligns the director's interests with the company's long-term performance.
• Employees may see the RSU grant as a sign of the company's commitment to its leadership team.

Key Dates

Keywords

Verona Pharma, RSU, Restricted Share Units, Director, Christina Ackermann, ADS, American Depositary Shares, Equity Compensation, Vesting